Mark D. Williams

J. Carcillo, Mark D. Williams, H. Dalton, 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients

Ranjit S. Chima, Mark D. Williams, R. Chima, 2019, Critical care explorations.

Implementation of a Care Management Model for Depression at Two Primary Care Clinics

D. Katzelnick, Mark D. Williams, K. Angstman, 2011, The Journal of ambulatory care management.

Production of a Polyhydroxyalkanoate Biopolymer in Insect Cells with a Modified Eucaryotic Fatty Acid Synthase

D. Sherman, Mark D. Williams, J. A. Rahn, 1996, Applied and Environmental Microbiology.

Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.

M. Effron, Mark D. Williams, N. Rajagopalan, 2004, American Journal of Health-System Pharmacy.

Role of the Bacillus methanolicus Citrate Synthase II Gene, citY, in Regulating the Secretion of Glutamate in l-Lysine-Secreting Mutants

E. Crabbe, C. Kaufmann, Mark D. Williams, 2003, Applied and Environmental Microbiology.

Development of Models to Simulate Tracer Behavior in Enhanced Geothermal Systems

Mark D. Williams, V. Vermeul, D. Newell, 2010 .

Modeling and process evaluation of membrane bioreactor for removing biodegradable organic matter from water

Mark D. Williams, M. Pirbazari, V. Ravindran, 2012 .

Early changes in organ function predict eventual survival in severe sepsis*

James A Russell, M. Levy, J. Vincent, 2005, Critical care medicine.

Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).

Massimo Antonelli, I. Douglas, M. Levy, 2007, American journal of respiratory and critical care medicine.

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

G. Bernard, J. Vincent, Mark D. Williams, 2003, Critical Care.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.

P. Barie, S. Lowry, J. Northrup, 2007, Surgery.

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care

Joseph Johnston, J. Johnston, Mark D. Williams, 2004, Critical care.

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

Mark D. Williams, F. Rubulotta, Mark D Williams, 2010, Critical Care Medicine.

Static and dynamic assessment of biomarkers in surgical patients with severe sepsis.

S. Lowry, D. Fry, H. Ford, 2004, Surgical infections.

IN PATIENTS WITH SEVERE SEPSIS, RENAL DYSFUNCTION IS PREDICTED BY SEVERE PROTEIN C DEFICIENCY, WHICH IS IMPROVED BY DROTRECOGIN ALFA ACTIVATED THERAPY.: 368

Mark D. Williams, D. Nelson, W. Macias, 2006 .

2002 Initial Assessments for B-BX-BY Field Investigation Report (FIR): Numerical Simulations

Mark D. Williams, C. Cole, M. White, 2002 .

Influence of Nitrate on the Hanford 100D Area In Situ Redox Manipulation Barrier Longevity

Mark D. Williams, V. Vermeul, J. Fruchter, 2005 .

In Situ Redox Manipulation Pilot Field Test : Remedial Design Support for ISRM Barrier Deployment Frontier Hard Chrome Superfund Site Vancouver , WA November , 2002

Mark D. Williams, V. Vermeul, J. Fruchter, 2003 .

Creation of a Subsurface Permeable Reactive Barrier Using In Situ Redox Manipulation

J. Amonette, Mark D. Williams, C. Cole, 2003 .

In Situ Redox Manipulation Pilot Field Test: Remedial Design Support for ISRM Barrier Deployment-Frontier Hard Chrome, Vancouver, Washington

Mark D. Williams, V. Vermeul, J. Fruchter, 2002 .

FOR TREATMENT OF CHROMATE IN GROUNDWATER AT THE HANFORD 100 D AREA : PARTNERSHIP FOR TECHNOLOGY DEPLOYMENT

Mark D. Williams, V. Vermeul, J. Fruchter, 2022 .

100-D Area In Situ Redox Treatability Test for Chromate-Contaminated Groundwater: FY 1998 Year-End Report

Mark D. Williams, C. Cole, V. Vermeul, 1999 .

Creation of a Subsurface Permeable Treatment Zone for Aqueous Chromate Contamination Using In Situ Redox Manipulation

J. Amonette, Mark D. Williams, C. Cole, 2000 .

Hanford Apatite Treatability Test Report Errata: Apatite Mass Loading Calculation

Mark D. Williams, V. Vermeul, J. Szecsody, 2014 .

Hanford 100-N Area In Situ Apatite and Phosphate Emplacement by Groundwater and Jet Injection: Geochemical and Physical Core Analysis

Mark D. Williams, M. Rockhold, V. Vermeul, 2010 .

Infiltration and Injection of a Ca-Citrate-PO4 Solution to Form Apatite In Situ for Sr-90 Remediation at the Hanford 100N Area – An Update

D. P. Mendoza, Mark D. Williams, V. Vermeul, 2010 .

100-NR-2 Apatite Treatability Test: An update on Barrier Performance

Mark D. Williams, V. Vermeul, B. Fritz, 2011 .

Best Practices for Systematic Case Review in Collaborative Care.

Amy M. Bauer, J. Unützer, Mark D. Williams, 2019, Psychiatric services.

Effectiveness in Regular Practice of Collaborative Care for Depression Among Adolescents: A Retrospective Cohort Study.

N. Shippee, Mark D. Williams, J. Huxsahl, 2018, Psychiatric services.

Safety of drotrecogin alfa (activated) in surgical patients with severe sepsis.

S. Lowry, D. Fry, G. Beilman, 2004, Surgical infections.

Challenges Associated with Apatite Remediation of Uranium in the 300 Area Aquifer

Mark D. Williams, V. Vermeul, J. Fruchter, 2008 .

Outcome of Electroconvulsive Therapy by Race in the Consortium for Research on Electroconvulsive Therapy Multisite Study

T. Rummans, M. Husain, S. Sampson, 2008, The journal of ECT.

Statins use and risk of depression: a systematic review and meta-analysis.

T. Rummans, M. Murad, C. West, 2014, Journal of affective disorders.

Forecasting the performance of membrane bioreactor process for groundwater denitrification

Mark D. Williams, M. Pirbazari, V. Ravindran, 2004 .

In-Situ Treatment Technologies

C. H. Ward, G. Pope, Mark D. Williams, 2002 .

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety.

M. Levy, J. Vincent, E. Abraham, 2007, Journal of critical care.

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.

P. Barie, S. Lowry, J. Northrup, 2006, Surgery.

Does the trait anxiety affect the dental fear?

J. Rohrer, Mark D. Williams, U. Aydogan, 2017, Brazilian oral research.

Differences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: results from a nationally representative sample

M. Frye, N. Shah, J. Ziegenfuss, 2011, Health and quality of life outcomes.

Drotrecogin alfa (activated) in adults with septic shock.

Andrew Rhodes, Didier Payen, Jyrki Tenhunen, 2012, The New England journal of medicine.

Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry

C. Sprung, M. Levy, G. Martin, 2010, Critical care.

ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*

Mark D. Williams, B. Giroir, M. Peters, 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Drotrecogin alfa (activated) treatment of older patients with severe sepsis.

G. Bernard, D. Angus, E. Ely, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

R. F. Johnston, Robert W. Taylor, Steven C. Johnson, 1994 .

Laparoscopic insufflation of the abdomen depresses cardiopulmonary function

Mark D. Williams, P. Murr, 2004, Surgical Endoscopy.

Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis.

Mark D. Williams, G. Vail, A. Shaw, 2011, Journal of critical care.

Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*

G. Bernard, T. van der Poll, J. Vincent, 2010, Critical care medicine.

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Mark D. Williams, B. Giroir, M. Peters, 2007, The Lancet.

Circulating endothelial and endothelial progenitor cells in patients with severe sepsis.

L. O'Brien, Mark D. Williams, A. Waxman, 2011, Microvascular research.

Laboratory study of the influence of scCO 2 injection on metals migration, precipitation, and microbial growth

Mark D. Williams, L. Zhong, M. Bowden, 2016 .

Membrane bioreactor process for removing biodegradable organic matter from water.

Mark D. Williams, M. Pirbazari, 2007, Water research.

Large-Scale Implementation of Collaborative Care Management for Depression and Diabetes and/or Cardiovascular Disease

R. Rossom, K. Coleman, A. Beck, 2018, The Journal of the American Board of Family Medicine.

Selective serotonin reuptake inhibitors and patients with carcinoid tumor.

Mark D. Williams, T. Dolenc, 2005, Psychosomatics.

Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).

G. Bernard, J. Dhainaut, S. Opal, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vasopressor Therapy in the Intensive Care Unit

N. Kissoon, A. Gordon, Mark D. Williams, 2020, Seminars in Respiratory and Critical Care Medicine.

Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis

John C. Marshall, Graham Ramsay, M. Levy, 2009, Critical care medicine.

Trials in adult critical care that show increased mortality of the new intervention: Inevitable or preventable mishaps?

Mark D. Williams, J. Russell, 2016, Annals of Intensive Care.

The Cost of Trauma

Mark D. Williams, D. Judkins, J. Porter, 2003, The American surgeon.

Impact of a national collaborative care initiative for patients with depression and diabetes or cardiovascular disease.

J. Unützer, R. Rossom, K. Coleman, 2017, General hospital psychiatry.

The COMPASS initiative: description of a nationwide collaborative approach to the care of patients with depression and diabetes and/or cardiovascular disease.

J. Unützer, K. Coleman, A. Beck, 2017, General hospital psychiatry.

Overcrowded Motor Vehicle Trauma from the Smuggling of Illegal Immigrants in the Desert of the Southwest

R. Latifi, Mark D. Williams, D. Judkins, 2004, The American surgeon.

Surgeon reimbursement for trauma care.

Mark D. Williams, D. Judkins, J. Porter, 2004, American journal of surgery.

Non-pharmacological treatment of depression: a systematic review and evidence map

Fares Alahdab, Zhen Wang, M. Murad, 2016, Evidence-Based Medicine.

Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study

M. Clark, C. Patten, J. Levine, 2017, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis.

P. Barie, S. Lowry, D. Fry, 2004, American journal of surgery.

Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis

Mark D. Williams, D. Nelson, A. Sashegyi, 2005, Critical care.

Hybrid membrane bioreactor technology for small water treatment utilities: Process evaluation and primordial considerations

Mark D. Williams, M. Pirbazari, V. Ravindran, 2009 .

evaluation of pH and ammonia for controlling bromate during Cryptosporidium disinfection

Mark D. Williams, S. Krasner, B. Coffey, 2003 .

International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH

Mark D. Williams, D. Nelson, A. Sashegyi, 2006, Current medical research and opinion.

Primary Care Utilization and Mental Health Diagnoses Among Adult Patients Requiring Interpreters: a Retrospective Cohort Study

M. Wieland, W. Kremers, L. Haas, 2013, Journal of General Internal Medicine.

Contaminants of Potential Concern in the 300-FF-5 Operable Unit: Expanded Annual Groundwater Report for Fiscal Year 2004

Eugene J. Freeman, Robert E. Peterson, Paul D. Thorne, 2005 .

Sustaining practice change one year after completion of the national depression management leadership initiative.

M. Trivedi, D. Katzelnick, D. Regier, 2013, Psychiatric Services.

Ephemeral thermal and solute plumes formed by upwelling groundwaters near salt domes

Mark D. Williams, V. Ranganathan, 1994 .

Sustainable care coordination: a qualitative study of primary care provider, administrator, and insurer perspectives

R. Jacobson, Mark D. Williams, L. F. Finney Rutten, 2019, BMC Health Services Research.

Understanding word preference for description of exercise interventions as a means for enhancing recruitment and acceptability of exercise treatment among adults treated for depression

C. Patten, J. Levine, P. Decker, 2014 .

Treatment Outcomes of Depression: The Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study

D. Schaid, R. Weinshilboum, J. Biernacka, 2014, Journal of clinical psychopharmacology.

Impact of socioeconomic status on depression clinical outcomes at six months in a Midwestern, United States community.

Gregory M. Garrison, C. Wi, Mark D. Williams, 2021, Journal of affective disorders.

Shared Decision Making for Antidepressants in Primary Care: A Cluster Randomized Trial.

Jonathan W. Inselman, V. Montori, J. Herrin, 2015, JAMA internal medicine.

Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

M. Levy, M. Antonelli, Mark D. Williams, 2009, Intensive Care Medicine.

Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death

Mark D. Williams, D. Nelson, J. Janes, 2006, Critical care.

Failure to Improve during First Day of Therapy Is Predictive of 28-Day Mortality in Severe Sepsi

M. Levy, J. Vincent, Mark D. Williams, 2003 .

USE OF TRACERS TO INTERROGATE FRACTURE SURFACE AREA IN SINGLE- WELL TRACER TESTS IN EGS SYSTEMS

Cynthia A. Dean, Mark D. Williams, Morgan G. Ames, 2012 .

An overview of the monitoring program design for the FutureGen 2.0 CO 2 storage site

Mark D. Williams, Vince R. Vermeul, Christopher E. Strickland, 2016 .

FutureGen 2.0 Monitoring Program: An Overview of the Monitoring Approach and Technologies Selected for Implementation

Paul D. Thorne, Vince R. Vermeul, Charlotte Sullivan, 2014 .

The Challenges of Collecting and Using Patient Care Data From Diverse Care Systems: Lessons From COMPASS

L. Solberg, J. Ziegenfuss, A. Crain, 2017, American journal of medical quality : the official journal of the American College of Medical Quality.

A system-based approach to depression management in primary care using the Patient Health Questionnaire-9.

K. Vickers, Mark D. Williams, R. DeJesus, 2007, Mayo Clinic proceedings.

Comparing the Beck Depression Inventory-II (BDI-II) and Patient Health Questionnaire (PHQ-9) depression measures in an integrated mood disorders practice.

Mark A Frye, Simon Kung, R. Alarcón, 2013, Journal of affective disorders.

Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.

Mark D. Williams, D. Payen, D. Nelson, 2007, Surgery.

IN-SITU REDOX MANIPULATION FOR TREATMENT OF CHROMATE IN GROUNDWATER AT THE HANFORD 100D AREA: PARTNERSHIP FOR TECHNOLOGY DEPLOYMENT

Mark D. Williams, J. Wright, V. Vermeul, 2000 .

Use of Gas Transported Reactants for Uranium Remediation in Vadose Zone Sediments

Mark D. Williams, L. Zhong, C. Resch, 2010 .

Methicillin-resistant staphylococcus aureus screening and eradication in the surgical intensive care unit: Is it worth it?

Mark D. Williams, J. W. Holmes, 2010, American journal of surgery.

Collaborative Care Management for Depression

Mark D. Williams, K. Angstman, R. DeJesus, 2010, Journal of primary care & community health.

Shared DecisionMaking for Antidepressants in Primary Care A Cluster Randomized Trial

Jonathan W. Inselman, V. Montori, J. Herrin, 2015 .

Antidepressant Medication Use Among Patients with Depression: Comparison between Usual Care and Collaborative Care Using Care Managers

S. Cha, Mark D. Williams, K. Angstman, 2013, Clinical practice and epidemiology in mental health : CP & EMH.

SustainingPracticeChangeOneYearAfter CompletionoftheNationalDepression ManagementLeadershipInitiative

M. Trivedi, D. Katzelnick, D. Regier, 2013 .

Impact of Collaborative Care for Depression on Clinical, Functional, and Work Outcomes: A Practice-Based Evaluation

N. Shippee, Mark D. Williams, J. Wilkinson, 2013, The Journal of ambulatory care management.

Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.

M. Frye, Mark D. Williams, D. Wood, 2011, Psychiatric services.

A quality improvement project aimed at adapting primary care to ensure the delivery of evidence-based psychotherapy for adult anxiety

D. Katzelnick, N. Shippee, Mark D. Williams, 2018, BMJ open quality.

Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis.

Mark D. Williams, G. Vail, A. Shaw, 2011, Journal of critical care.

Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

H. Wong, M. Bigham, Mark D. Williams, 2008, American journal of respiratory and critical care medicine.